BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34928233)

  • 21. KDM5c inhibits multidrug resistance of colon cancer cell line by down-regulating ABCC1.
    Lin H; Yang G; Yu J; Wang J; Li Q; Guo S; Cao B
    Biomed Pharmacother; 2018 Nov; 107():1205-1209. PubMed ID: 30257334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Knockdown of Chitinase 3-Like-1 Inhibits Cell Proliferation, Promotes Apoptosis, and Enhances Effect of Anti-Programmed Death Ligand 1 (PD-L1) in Diffuse Large B Cell Lymphoma Cells.
    Yang X; Fang D; Li M; Chen J; Cheng Y; Luo J
    Med Sci Monit; 2021 Mar; 27():e929431. PubMed ID: 33764958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. KDM5C is transcriptionally regulated by BRD4 and promotes castration-resistance prostate cancer cell proliferation by repressing PTEN.
    Hong Z; Wu G; Xiang ZD; Xu CD; Huang SS; Li C; Shi L; Wu DL
    Biomed Pharmacother; 2019 Jun; 114():108793. PubMed ID: 30921702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of MELK Inhibitor OTSSP167 on Diffuse Large B-Cell Lymphoma].
    Zhou JY; Huang H; Zhuang Y; Zhong XM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):739-745. PubMed ID: 37356934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lysine (K)-specific demethylase 5C regulates the incidence of severe preeclampsia by adjusting the expression of bone morphogenetic protein-7.
    Shi XF; Zhang Z; Wu HY; Wang Y; Chang AM; Gao JJ; Liu K; Song WY; Wang L; Wang HP
    Bioengineered; 2022 Apr; 13(4):8538-8547. PubMed ID: 35331081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. METTL3 enhances the effect of YTHDF1 on NEDD1 mRNA stability by m6A modification in diffuse large B-cell lymphoma cells.
    Feng L; Yan Q; Pan H; Shi W
    Immun Inflamm Dis; 2023 Feb; 11(2):e789. PubMed ID: 36840486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of 2-12alkyl-6-methoxycyclohexa-2, 5-diene-1, 4-dione(DMDD)on diffuse large B lymphoma and its mechanism].
    Hong K; Jiang PR; Ke RJ; Ying JH; Zhang XY; Chen JY
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2019 Jul; 35(4):312-316. PubMed ID: 31701713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathologic implication of microRNA-197 in diffuse large B cell lymphoma.
    Yang JM; Jang JY; Jeon YK; Paik JH
    J Transl Med; 2018 Jun; 16(1):162. PubMed ID: 29890998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-214 prevents the progression of diffuse large B-cell lymphoma by targeting PD-L1.
    Sun JR; Zhang X; Zhang Y
    Cell Mol Biol Lett; 2019; 24():68. PubMed ID: 31844419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lysine demethylase 5C epigenetically reduces transcription of ITIH1 that results in augmented progression of liver hepatocellular carcinoma.
    Qian X; Bao ZM; Yao D; Shi Y
    Kaohsiung J Med Sci; 2022 May; 38(5):437-446. PubMed ID: 35080113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Potential mechanism and prognostic value of promoter methylation of PRDM1 gene in diffuse large B cell lymphoma].
    Zhang XY; Ma ZP; Cui WL; Chen R; Glinaer A; Miao N; Li XX
    Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):831-837. PubMed ID: 28056297
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effects of Silencing NSD2 Gene by shRNA on Proliferation, Apoptosis and Akt /mTOR Signal Pathway in OCI-Ly3 Cells].
    Guo MX; Zou Y; Lin LH; Ma XD; Huang YQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Jun; 26(3):772-778. PubMed ID: 29950218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and clinical significance of miR-23a and MTSS1 in diffuse large B-cell lymphoma.
    Xu M; Xu T
    Oncol Lett; 2018 Jul; 16(1):371-377. PubMed ID: 29928423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Soluble CXCL16 promotes TNF-α-induced apoptosis in DLBCL via the AMAD10-NF-κB regulatory feedback loop.
    Yang H; Qiu B; Chen S; Xun Y; Pan Y; Chen M; Li WX; Liao W; El-Ashram S; Yang A; Liu F
    Cell Biol Int; 2019 Aug; 43(8):863-874. PubMed ID: 31033093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CircRNA_OTUD7A upregulates FOXP1 expression to facilitate the progression of diffuse large B-cell lymphoma via acting as a sponge of miR-431-5p.
    Liu W; Lei L; Liu X; Ye S
    Genes Genomics; 2021 Jun; 43(6):653-667. PubMed ID: 33830472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence.
    Kahl P; Gullotti L; Heukamp LC; Wolf S; Friedrichs N; Vorreuther R; Solleder G; Bastian PJ; Ellinger J; Metzger E; Schüle R; Buettner R
    Cancer Res; 2006 Dec; 66(23):11341-7. PubMed ID: 17145880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. lncRNA GAS5, as a ceRNA, inhibits the proliferation of diffuse large B‑cell lymphoma cells by regulating the miR‑18a‑5p/RUNX1 axis.
    Miao Y; Chen X; Qin M; Zhou W; Wang Y; Ji Y
    Int J Oncol; 2021 Nov; 59(5):. PubMed ID: 34698360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-9 promotes cell survival and drug resistance in diffuse large B-cell lymphoma.
    Lv X; Feng L; Ge X; Lu K; Wang X
    J Exp Clin Cancer Res; 2016 Jul; 35(1):106. PubMed ID: 27364124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arsenic disulfide induces apoptosis of human diffuse large B cell lymphoma cells involving Bax cleavage.
    Wang L; Liu X; Li X; Lv X; Lu K; Chen N; Li P; Wang X
    Oncol Rep; 2013 Nov; 30(5):2427-34. PubMed ID: 24026139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LINC00511 promotes the progression of non-small cell lung cancer through downregulating LATS2 and KLF2 by binding to EZH2 and LSD1.
    Zhu FY; Zhang SR; Wang LH; Wu WD; Zhao H
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8377-8390. PubMed ID: 31646568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.